Why do we still need large scale clinical trial: The case of n-3 PUFA

Frontiers in Physiology

Volumn 3 JUN, Issue , 2012, Pages

  Marchioli, Roberto ^a,b   Levantesi, Giacomo ^a,c  

^a Consorzio Mario Negri Sud ^*  (Italy)

^b Italian Society of Cardiology Research Center   (Italy)

^c S Pio Hospital Vasto ^*  (Italy)

Author keywords

Clinical trials; N 3 polyunsaturated fatty acids; Review

Indexed keywords

EID: 84866391069     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00202     Document Type: Review

References (75)

1. Albert, C. M., Campos, H., Stampfer, M. J., Ridker, P. M., Manson, J. E., Willett, W. C., and Ma, J. (2002). Blood levels of long-chain n-3 fatty acids and therisk of sudden death. N. Engl. J. Med. 346, 1113-1118.
2. Albert, C. M., Hennekens, C. H., O'Donnell, C. J., Ajani, U. A., Carey, V. J., Willett, W. C., Ruskin, J. N., and Manson, J. E. (1998). Fish consumption and risk of sudden cardiac death. JAMA 279, 23-28.
3. Bang, H. O., and Dyerberg, J. (1972). Plasma lipids and lipoproteins in Greenlandic west coast Eskimos. Acta Med. Scand. 192, 85-94.
4. Bang,H. O.,Dyerberg,J., and Nielsen,A. B. (1971). Plasma lipid and lipopro-tein pattern in Greenlandic West-coast Eskimos. Lancet 1, 1143-1145.
5. Barzi, F., Woodward, M., Marfisi, R. M., Tavazzi, L., Valagussa, F., and Marchioli,R. (2003). Mediterranean diet and all-causes mortality after myocardial infarction: results from the GISSI-Prevenzione trial. Eur. J. Clin. Nutr. 57, 604-611.
6. Billman, G. E., Kang, J. X., and Leaf, A. (1999). Prevention of sudden cardiac death by dietary pure omega-3 polyunsaturated fatty acids in dogs. Circulation 99, 2452-2457.
7. Biscione, F., Totteri, A., De Vita, A., Lo Bianco, F., and Altamura, G. (2005). Effect of omega-3 fatty acids on the prevention of atrial arrhythmias. Ital. Heart J. Suppl. 6, 53-59.
8. Brouwer, I. A., Raitt, M. H., Dullemei-jer, C., Kraemer, D. F., Zock, P. L., Morris, C., Katan, M. B., Connor, W. E., Camm, J. A., Schouten, E. G., and Mcanulty, J. (2009). Effect of fish oil on ventricular tachyarrhyth-mia in three studies in patients with implantable cardioverter defibrillators. Eur. Heart J. 30, 820-826.
9. Brouwer, I. A., Zock, P. L., Camm, A. J., Bocker, D., Hauer, R. N., Wever, E. F., Dullemeijer, C., Ronden, J. E., Katan, M. B., Lubinski, A., Buschler, H., and Schouten, E. G. (2006). Effect of fish oil on ventricular tach-yarrhythmia and death in patients with implantable cardioverter defib-rillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomizedtrial. JAMA 295, 2613-2619.
10. Burr, M. L., Ashfield-Watt, P. A., Dun-stan, F. D., Fehily, A. M., Breay, P., Ashton, T., Zotos, P. C., Haboubi, N. A., and Elwood, P. C. (2003). Lack of benefit of dietary advice to men with angina: results of a controlled trial. Eur. J. Clin. Nutr. 57, 193-200.
11. Burr, M. L., Fehily, A. M., Gilbert, J. F., Rogers, S., Holliday, R. M., Sweetnam, P. M., Elwood, P. C., and Deadman, N. M. (1989). Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 2, 757-761.
12. Calo, L., Bianconi, L., Colivicchi, F., Lamberti, F., Loricchio, M. L., De Ruvo, E., Meo, A., Pandozi, C., Staibano,M.,and Santini, M. (2005). N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J. Am. Coll. Cardiol. 45, 1723-1728.
13. Camm, A. J., and Savelieva, I. (2011). Fish oil for secondary prevention of atrial fibrillation: should we still believe in its antiar-rhythmic effect? Circulation 124, 1093-1096.
14. Christensen, J. H., Korup, E., Aaroe, J., Toft, E., Moller, J., Rasmussen, K., Dyerberg, J., and Schmidt, E. B. (1997). Fish consumption, n-3 fatty acids in cell membranes, and heart rate variability in survivors of myocardial infarction with left ven tricular dysfunction. Am. J. Cardiol. 79, 1670-1673.
15. De Lorgeril, M., Renaud, S., Mamelle, N., Salen, P., Martin, J. L., Mon-jaud, I., Guidollet, J., Touboul, P., and Delaye, J. (1994). Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 343, 1454-1459.
16. Filion, K. B., El Khoury, F., Bielin-ski, M., Schiller, I., Dendukuri, N., and Brophy, J. M. (2010). Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials. BMC Cardiovasc. Disord. 10, 24. doi:10.1186/1471-2261-10-24
17. Finzi, A. A., Latini, R., Barlera, S., Rossi, M. G., Ruggeri, A., Mezzani, A., Favero, C., Franzosi,M. G., Serra, D., Lucci, D., Bianchini, F., Bernasconi, R., Maggioni, A. P., Nicolosi, G., Porcu, M., Tognoni, G., Tavazzi, L., and Marchioli, R. (2011). Effects of n-3 polyunsaturated fatty acids on malignant ventricular arrhythmias in patients with chronic heart failure and implantable cardioverter-defibrillators: a substudy of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca (GISSI-HF) trial. Am. Heart J. 161, 338-343.e331.
18. Galan, P., Kesse-Guyot, E., Czernichow, S., Briancon, S., Blacher, J., Her-cberg, S., and Group, S. F. O. C. (2010). Effects of B vitamins and omega 3 fatty acids on car diovascular diseases: a randomised placebo controlled trial. BMJ 341, c6273.
19. Ghio, S., Scelsi, L., Latini, R., Mas-son, S., Eleuteri, E., Palvarini, M., Vriz, O., Pasotti, M., Gorini, M., Marchioli, R., Maggioni, A., Tavazzi, L., and Investigators, G.-H. (2010). Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI-HF trial. Eur. J. Heart Fail. 12, 1345-1353.
20. Graham, I., Atar, D., Borch-Johnsen, K., Boysen, G., Burell, G., Cifkova, R., Dallongeville, J., De Backer, G., Ebrahim, S., Gjelsvik, B., Herrmann-Lingen, C., Hoes, A., Humphries, S., Knapton, M., Perk, J., Priori, S. G., Pyorala, K., Reiner, Z., Ruilope, L., Sans-Menendez, S., Op Reimer, W. S., Weissberg, P., Wood, D., Yarnell, J., Zamorano, J. L., Walma, E., Fitzgerald, T., Cooney, M. T., Dudina, A., Vahanian, A., Camm, J., De Caterina, R., Dean, V., Dickstein, K., Funck-Brentano, C., Filippatos, G., Hellemans, I., Kristensen, S. D., Mcgregor, K., Sechtem, U., Silber, S., Tendera, M., Widimsky, P., Altiner, A., Bonora, E., Durrington, P. N., Fagard, R., Giampaoli, S., Hemingway, H., Hakansson, J., Kjeldsen, S. E., Larsen, M. L., Mancia, G., Manolis, A. J., Orth-Gomer, K., Pedersen, T., Rayner, M., Ryden, L., Sammut, M., Schneiderman, N., Stalenhoef, A. F., Tokgozoglu, L., Wiklund, O., and Zampelas, A. (2007). European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur. J. Cardiovasc. Prev. Rehabil. 14(Suppl. 2), E1-E40.
21. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. (1999). Dietary supplementation with n-3 polyun-saturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354, 447-455.
22. He, K., Song, Y., Daviglus, M. L., Liu, K., Van Horn, L., Dyer, A. R., and Greenland, P. (2004). Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation 109, 2705-2711.
23. Heart Protection Study Collaborative Group. (2002). MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360, 7-22.
24. Hooper, L., Thompson, R. L., Harrison, R. A., Summerbell, C. D., Moore, H., Worthington, H. V., Durring-ton, P. N., Ness, A. R., Capps, N. E., Davey Smith, G., Riemersma, R. A., and Ebrahim, S. B. (2004). Omega 3 fatty acids for prevention and treatment of cardiovascular disease. Cochrane Database Syst. Rev. CD003177.
25. Hooper, L., Thompson, R. L., Harrison, R. A., Summerbell, C. D., Ness, A. R., Moore, H. J., Worthing-ton, H. V., Durrington, P. N., Hig-gins, J. P., Capps, N. E., Riemersma, R. A., Ebrahim, S. B., and Davey Smith, G. (2006). Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review. BMJ 332, 752-760.
26. Iso, H., Kobayashi, M., Ishihara, J., Sasaki, S., Okada, K., Kita, Y., Kokubo, Y., and Tsugane, S. (2006). Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort I. Circulation 113, 195-202.
27. Jenkins, D. J., Josse, A. R., Beyene, J., Dorian, P., Burr, M. L., Labelle, R., Kendall, C. W., and Cunnane, S. C. (2008). Fish-oil supplementation in patients with implantable car-dioverter defibrillators: a meta-analysis. CMAJ 178, 157-164.
28. Kang, J. X., and Leaf, A. (1994). Effects of long-chain polyunsaturated fatty acids on the contraction of neonatal rat cardiac myocytes. Proc. Natl. Acad. Sci. U.S.A. 91, 9886-9890.
29. Kang, J. X., and Leaf, A. (1995). Prevention and termination of beta-adrenergic agonist-induced arrhythmiasbyfree polyunsaturated fatty acids in neonatal rat cardiac myocytes. Biochem. Biophys. Res. Commun. 208, 629-636.
30. Kang, J. X., and Leaf, A. (1996). Antiar-rhythmic effects of polyunsaturated fatty acids. Recent studies. Circulation 94, 1774-1780.
31. Kang, J. X., Xiao, Y. F., and Leaf, A. (1995). Free, long-chain, polyunsaturated fatty acids reduce membrane electrical excitability in neonatal rat cardiac myocytes. Proc. Natl. Acad. Sci. U.S.A. 92, 3997-4001.
32. Kotseva, K., Wood, D., De Backer, G., De Bacquer, D., Pyorala, K., Keil, U., and Group, E. S. (2009a). Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet 373, 929-940.
33. Kotseva, K., Wood, D., De Backer, G., De Bacquer, D., Pyorala, K., Keil, U., and EUROASPIRE Study Group. (2009b). EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur. J. Cardiovasc. Prev. Rehabil. 16, 121-137.
34. Kowey, P. R., Reiffel, J. A., Ellenbogen, K. A., Naccarelli, G. V., and Pratt, C. M. (2010). Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: arandomized controlledtrial. JAMA 304, 2363-2372.
35. Kromhout, D., Giltay, E. J., Geleijnse, J. M., and Alpha Omega Trial Group. (2010). n-3 fatty acids and cardiovascular events after myocardial infarction. N. Engl. J. Med. 363, 2015-2026.
36. Kwak, S. M., Myung, S. K., Lee, Y. J., Seo, H. G., and For the Korean Meta-Analysis Study Gruop. (2012). Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials. Arch. Intern. Med. doi: 10.1001/archinternmed. 2012.262. [Epub ahead of print].
37. Leaf, A. (1999). Dietary prevention of coronary heart disease: the Lyon Diet Heart Study. Circulation 99, 733-735.
38. Leaf, A., Albert, C. M., Josephson, M., Steinhaus, D., Kluger, J., Kang, J. X., Cox, B., Zhang, H., and Schoenfeld, D. (2005). Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation 112, 2762-2768.
39. Leaf, A., Kang, J. X., Xiao, Y. F., and Billman, G. E. (2003). Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation 107, 2646-2652.
40. Leon, H., Shibata, M. C., Sivaku-maran, S., Dorgan, M., Chatter-ley, T., and Tsuyuki, R. T. (2008). Effect of fish oil on arrhythmias and mortality: systematic review. BMJ 337, a2931.
41. Liu, T., Korantzopoulos, P., Shehata, M., Li, G., Wang, X., and Kaul, S. (2011). Prevention of atrial fibrillation with omega-3 fatty acids: a meta-analysis of randomised clinical trials. Heart 97, 1034-1040.
42. Macchia, A., Levantesi, G., Fran-zosi, M. G., Geraci, E., Mag-gioni, A. P., Marfisi, R., Nicolosi, G. L., Schweiger, C., Tavazzi, L., Tognoni, G., Valagussa, F., and Marchioli, R. (2005). Left ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n-3 polyunsaturated fatty acids. Eur. J. Heart Fail. 7, 904-909.
43. Marchioli, R., Barzi, F., Bomba, E., Chi-effo, C., Di Gregorio, D., di Mascio, R., Franzosi, M. G., Geraci, E., Lev-antesi, G., Maggioni, A. P., Mantini, L., Marfisi, R. M., Mastrogiuseppe, G., Mininni, N., Nicolosi, G. L., Santini, M., Schweiger, C., Tavazzi, L., Tognoni, G., Tucci, C., and Valagussa, F. (2002). Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Soprav-vivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 105, 1897-1903.
44. Marchioli, R., Silletta, M. G., Levantesi, G., and Pioggiarella, R. (2009). Omega-3 fatty acids and heart failure. Curr. Atheroscler. Rep. 11, 440-447.
45. Marckmann, P., and Gronbaek, M. (1999). Fish consumption and coronary heart disease mortality. A systematic review of prospective cohort studies. Eur. J. Clin. Nutr. 53, 585-590.
46. Marik, P. E., and Varon, J. (2009). Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review. Clin. Cardiol. 32, 365-372.
47. McLennan, P. L., Bridle, T. M., Abey-wardena, M. Y., and Charnock, J. S. (1992). Dietary lipid modulation of ventricular fibrillation threshold in the marmoset monkey. Am. Heart J. 123, 1555-1561.
48. McLennan, P. L., Bridle, T. M., Abeywardena, M. Y., and Charnock, J. S. (1993). Comparative efficacy of n-3 and n-6 polyunsaturated fatty acids in modulating ventricular fibrillation threshold in marmoset monkeys. Am. J. Clin. Nutr. 58, 666-669.
49. Mente, A., De Koning, L., Shannon, H. S., and Anand, S. S. (2009). A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch. Intern. Med. 169, 659-669.
50. Mozaffarian, D., Marchioli, R., Gardner, T., Ferrazzi, P., O'Gara, P., Latini, R., Libby, P., Lombardi, F., Macchia, A., Page, R., Santini, M., Tavazzi, L., and Tognoni, G. (2011). The omega-3 fatty acids for prevention of post-operative atrial fibrillation trial - rationale and design. Am. Heart J. 162, 56-63.e53.
51. Mozaffarian, D., and Rimm, E. B. (2006). Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 296, 1885-1899.
52. Nilsen, D. W., Albrektsen, G., Landmark, K., Moen, S., Aarsland, T., and Woie, L. (2001). Effects of a high-dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol. Am. J. Clin. Nutr. 74, 50-56.
53. Nodari, S., Triggiani, M., Campia, U., Manerba, A., Milesi, G., Cesana, B. M., Gheorghiade, M., and Dei Cas, L. (2011). n-3 polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion: a prospective, randomized study. Circulation 124, 1100-1106.
54. Pisters, R., Nieuwlaat, R., Prins, M. H., Le Heuzey, J. Y., Maggioni, A. P., Camm, A. J., Crijns, H. J., and For the Euro Heart Survey Investigators. (2012). Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey. Europace. 14, 666-674.
55. Raitt, M. H., Connor, W. E., Morris, C., Kron, J., Halperin, B., Chugh, S. S., Mcclelland, J., Cook, J., Macmurdy, K., Swenson, R., Connor, S. L., Gerhard, G., Kraemer, D. F., Oseran, D., Marchant, C., Calhoun, D., Shnider, R., and McAnulty,J. (2005). Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial. JAMA 293, 2884-2891.
56. Rauch, B., Schiele, R., Schneider, S., Diller, F., Victor, N., Gohlke, H., Gottwik, M., Steinbeck, G., Del Castillo, U., Sack, R., Worth, H., Katus, H., Spitzer, W., Sabin, G., and Senges, J. (2010). OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction. Circulation 122, 2152-2159.
57. Rauch, B., Schiele, R., Schneider, S., Gohlke, H., Diller, F., Gottwik, M., Steinbeck, G., Heer, T., Katus, H., Zimmer, R., Erdogan, A., Pfafferott, C., and Senges, J. (2006). Highly purified omega-3 fatty acids for secondary preventionofsuddencardiac death after myocardial infarction-aims and methods of the OMEGA-study. Cardiovasc. Drugs Ther. 20, 365-375.
58. Savelieva, I., Kakouros, N., Kourliouros, A., and Camm, A. J. (2011). Upstreamtherapies formanagement of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention. Europace 13, 610-625.
59. Sellmayer, A., Witzgall, H., Lorenz, R. L., and Weber, P. C. (1995). Effects of dietary fish oil on ventricular premature complexes. Am. J. Cardiol. 76, 974-977.
60. Singh, R. B., Niaz, M. A., Sharma, J. P., Kumar, R., Rastogi, V., and Moshiri, M. (1997). Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival - 4. Cardiovasc. Drugs Ther. 11, 485-491.
61. Siscovick, D. S., Raghunathan, T. E., King, I., Weinmann, S., Wicklund, K. G., Albright, J., Bovbjerg, V., Arbogast, P., Smith, H., Kushi, L. H., Cobb, L. A., Copass, M. K., Psaty, B. M., Lemaitre, R., Retzlaff, B., Childs, M., and Knopp, R. H. (1995). Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 274, 1363-1367.
62. Skuladottir, G. V., Heidarsdottir, R., Arnar, D. O., Torfason, B., Edvards-son, V., Gottskalksson, G., Palsson, R., and Indridason, O. S. (2011). Plasma n-3 and n-6 fatty acids and the incidence of atrial fibrillation following coronary artery bypass graft surgery. Eur. J. Clin. Invest. 41, 995-1003.
63. Suzuki, T., Yamazaki, T., Ogawa, S., Nagai, R., Yamashita, T., and Investigators, J. R. I. (2011). Echocardio-graphic predictors of frequency of paroxysmal atrial fibrillation (AF) and its progression to persistent AF in hypertensive patients with paroxysmal AF: results from the Japanese Rhythm Management Trial II for Atrial Fibrillation (J-RHYTHM II Study). Heart Rhythm 8, 1831-1836.
64. Tavazzi, L., Maggioni, A. P., Marchioli, R., Barlera, S., Franzosi, M. G., Latini, R., Lucci, D., Nicolosi, G. L., Porcu, M., and Tognoni, G. (2008). Effect of n-3 polyunsatu-rated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 372, 1223-1230.
65. Tavazzi, L., Tognoni, G., Franzosi,M. G., Latini, R., Maggioni,A. P., Marchioli, R., Nicolosi, G. L., and Porcu, M. (2004). Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsat-urated fatty acids and rosuvastatin in symptomatic congestive heart failure. Eur. J. Heart Fail. 6, 635-641.
66. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. (1998). Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N. Engl. J. Med. 339, 1349-1357.
67. Von Schacky, C., and Harris, W. S. (2007). Cardiovascular benefits of omega-3 fatty acids. Cardiovasc. Res. 73, 310-315.
68. Von Schacky, C., Harris, W. S., Mozaf-farian, D., and Kris-Etherton, P. M. (2006). Response to Hoopers et al. Cochrane Review [Online]. Available at: http:// www.issfal.org/statements/hooper-rebuttable [accessed September 16, 2009].
69. 2+ currents by polyunsatu-rated fatty acids in adult and neonatal rat ventricular myocytes. Proc. Natl. Acad. Sci. U.S.A. 94, 4182-4187.
70. Xiao, Y. F., Kang, J. X., Morgan, J. P., and Leaf, A. (1995). Blocking effects of polyunsaturated fatty acids on Na+ channels of neonatal rat ventricular myocytes. Proc. Natl. Acad. Sci. U.S.A. 92, 11000-11004.
71. Xiao, Y. F., Wright, S. N., Wang, G. K., Morgan, J. P., and Leaf, A. (1998). Fatty acids suppress voltage-gated Na+ currents in HEK293t cells transfected with the alpha-subunit of the human cardiac Na+ channel. Proc. Natl. Acad. Sci. U.S.A. 95, 2680-2685.
72. Yokoyama, M., Origasa, H., Mat-suzaki, M., Matsuzawa, Y., Saito, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., Kita, T., Kitabatake, A., Nakaya, N., Sakata, T., Shimada, K., and Shirato, K. (2007). Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 369, 1090-1098.
73. Yusuf, S., Sleight, P., Pogue, J., Bosch, J., Davies, R., and Dagenais, G. (2000). Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N. Engl. J. Med. 342, 145-153.
74. Zatonski, W., Campos, H., and Willett, W. (2008). Rapid declines in coronary heart disease mortality in Eastern Europe are associated with increased consumption of oils rich in alpha-linolenic acid. Eur. J. Epidemiol. 23, 3-10.
75. Zhao, Y. T., Chen, Q., Sun, Y. X., Li, X. B., Zhang, P., Xu, Y., and Guo, J. H. (2009). Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: a meta-analysis of randomized controlled trials. Ann. Med. 41, 301-310.